Clinical scoring demonstrates the greater predictive capability for melioidosis pneumonia.
作者信息
Mohapatra Prasanta Raghab, Behera Bijayini
机构信息
Department of Pulmonary Medicine and Critical Care, AII India Institute of Medical Sciences, Bhubaneswar, India.
Department of Microbiology, AII India Institute of Medical Sciences, Bhubaneswar, India.
出版信息
Quant Imaging Med Surg. 2024 Dec 5;14(12):9845-9847. doi: 10.21037/qims-24-1327. Epub 2024 Sep 13.
Abstract
摘要
相似文献
1
Clinical scoring demonstrates the greater predictive capability for melioidosis pneumonia.临床评分显示对类鼻疽肺炎具有更强的预测能力。
Quant Imaging Med Surg. 2024 Dec 5;14(12):9845-9847. doi: 10.21037/qims-24-1327. Epub 2024 Sep 13.
2
Clinico-microbiological description and evaluation of rapid lateral flow immunoassay and PCR for detection of Burkholderia pseudomallei from patients hospitalized with sepsis and pneumonia: A twenty-one months study from Odisha, India.从印度奥里萨邦一项为期 21 个月的研究：对快速侧向流动免疫测定和 PCR 检测败血症和肺炎住院患者中类鼻疽伯克霍尔德菌的临床微生物学描述和评估。
Acta Trop. 2021 Sep;221:105994. doi: 10.1016/j.actatropica.2021.105994. Epub 2021 Jun 9.
3
A proposed scoring system for predicting mortality in melioidosis.
Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):577-81. doi: 10.1016/s0035-9203(03)80035-4.
4
Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature.类鼻疽肺炎的临床特征和流行病学：21 年研究结果及文献回顾。
Clin Infect Dis. 2012 Feb 1;54(3):362-9. doi: 10.1093/cid/cir808. Epub 2011 Nov 4.
5
A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis.一种用于区分复发性类鼻疽患者复发与再感染的简易评分系统。
PLoS Negl Trop Dis. 2008;2(10):e327. doi: 10.1371/journal.pntd.0000327. Epub 2008 Oct 29.
6
Bacteraemic melioidosis pneumonia: impact on outcome, clinical and radiological features.菌血症性类鼻疽肺炎：对预后、临床及影像学特征的影响
J Infect. 2004 May;48(4):334-8. doi: 10.1016/j.jinf.2003.10.005.
7
Clinical characteristics and predictors of mortality in patients with melioidosis: the Kapit experience.类鼻疽病患者的临床特征和死亡预测因素：加帛经验。
Trop Med Int Health. 2021 Jun;26(6):664-671. doi: 10.1111/tmi.13563. Epub 2021 Mar 3.
8
Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Association.他汀类药物的使用与类鼻疽患者肺炎风险降低的相关性：一种肺部特异性他汀类药物关联。
Ann Am Thorac Soc. 2024 Feb;21(2):228-234. doi: 10.1513/AnnalsATS.202306-552OC.
9
Successful treatment outcome of primary melioidosis pneumonia-a case report from Bangladesh.原发性类鼻疽肺炎的成功治疗结果——来自孟加拉国的一例病例报告
BMC Res Notes. 2016 Feb 16;9:100. doi: 10.1186/s13104-016-1910-0.
10
Melioidosis--an uncommon but also under-recognized cause of pneumonia in Papua New Guinea.类鼻疽病——巴布亚新几内亚一种不常见但也未得到充分认识的肺炎病因。
P N G Med J. 2010 Sep-Dec;53(3-4):176-9.
本文引用的文献
1
A new computed tomography score-based staging for melioidosis pneumonia to predict progression.一种基于计算机断层扫描评分的类鼻疽肺炎分期方法，用于预测病情进展。
Quant Imaging Med Surg. 2024 Jun 1;14(6):3863-3874. doi: 10.21037/qims-23-1476. Epub 2024 May 10.
2
Radiological perspective of COVID-19 pneumonia: The early features and progressive behaviour on high-resolution CT.COVID-19 肺炎的放射学观点：高分辨率 CT 的早期特征和进展表现。
J Med Imaging Radiat Oncol. 2021 Apr;65(2):208-212. doi: 10.1111/1754-9485.13139. Epub 2021 Jan 24.
3
Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide.《COVID-19 诊断和管理中胸部成像的应用：世卫组织快速建议指南》。
Radiology. 2021 Feb;298(2):E63-E69. doi: 10.1148/radiol.2020203173. Epub 2020 Jul 30.
4
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率，1990-2017 年：全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
5
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.心力衰竭、急性心肌梗死或肺炎患者住院后 30 天内再入院的诊断和时间。
JAMA. 2013 Jan 23;309(4):355-63. doi: 10.1001/jama.2012.216476.
6
Melioidosis.类鼻疽
N Engl J Med. 2012 Sep 13;367(11):1035-44. doi: 10.1056/NEJMra1204699.
7
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.SMART-COP：一种预测社区获得性肺炎患者是否需要强化呼吸支持或血管活性药物支持的工具。
Clin Infect Dis. 2008 Aug 1;47(3):375-84. doi: 10.1086/589754.
8
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.在患者入院时定义社区获得性肺炎的严重程度：一项国际推导与验证研究。
Thorax. 2003 May;58(5):377-82. doi: 10.1136/thorax.58.5.377.
9
A prediction rule to identify low-risk patients with community-acquired pneumonia.一种用于识别社区获得性肺炎低风险患者的预测规则。
N Engl J Med. 1997 Jan 23;336(4):243-50. doi: 10.1056/NEJM199701233360402.
Zotero 插件